The Retinal Genix plans to use the facility to further the development of its DNA/RNA/GPS Pharmaco-Genetic Mapping platform. RetinalGenix has signed a new laboratory lease agreement with life science ...

Preclinical data on the use of Purified Cortrophin Gel (repository corticotropin injection USP) was recently announced by ANI Pharmaceuticals. 1 Cotrophin Gel is a prescription injection indicated for ...

In an analysis of the IRIS database, investigators assessed almost 1,200 eyes that had been treated with faricimab. At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, ...

The PRISM clinical trial assesses 4D-150 (4D Molecular Therapeutics) in adults with neovascular age-related macular degeneration, also known as wet AMD. At the 2025 Association for Research in Vision ...

KIO-104 is a therapeutic candidate shown to significantly reduce retinal scar formation. KIO-104, a small molecular DHODH inhibitor, works by suppressing T cell replication and function. The ...

Chengdu Origen Biotechnology Co, Ltd. And Vanotech Ltd. recently announced the dosing of the first patient in the VAN-2401 multi-center phase 1 clinical trial (NCT06825858). 1 The VAN-2401 clinical ...

Lukas Scheibler, PhD, has been appointed as chief research and development officer and Graham Cooper as chief financial officer of Tavo Biotherapeutics, the company recently announced. 1 “I am ...

The 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting will take place May 4-8, 2025, in Salt Lake City, Utah. This meeting will feature presenter and researcher from ...

The OcuMet Beacon is a proprietary, noninvasive tool for assessing retinal health. The company said it will be available on the US market for use in clinics and healthcare institutions. The US Food ...

A panelist discusses how a woman aged 77 years with bilateral neovascular age-related macular degeneration (nAMD) demonstrated different responses to treatments between her eyes, showing a superior ...

A panelist discusses how a man aged 79 years with long-duration diabetes and treatment-naive diabetic macular edema (DME) responded well to aflibercept 8-mg therapy, progressing from 4-week loading ...

Retina World Congress 2025 is set to take place in Fort Lauderdale, Florida on May 8 through May 11, 2025. This meeting brings together retina specialists from around the globe to discuss research ...